RecruitingNCT01890486

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

The Prospective Collection, Storage and Reporting of Data on Patients


Sponsor

Wake Forest University Health Sciences

Enrollment

2,000 participants

Start Date

May 21, 2001

Study Type

OBSERVATIONAL

Conditions

Summary

To provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed.


Eligibility

Min Age: 18 YearsMax Age: 120 Years

Plain Language Summary

Simplified for easier understanding

This study prospectively collects health data and outcomes from patients undergoing a bone marrow transplant (either from a donor or using their own stem cells) using a standard treatment regimen, to build a long-term record that helps improve transplant care. **You may be eligible if...** - You are scheduled to receive a standard high-dose treatment followed by either an allogeneic (donor) or autologous (your own cells) bone marrow transplant as part of your clinical care **You may NOT be eligible if...** - You are currently enrolled in another treatment research protocol Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Wake Forest Baptist Health

Winston-Salem, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01890486


Related Trials